Efficacy of Initial Basal-Supported Oral Therapy with Sitagliptin in Untreated Type 2 Diabetes

INTRODUCTION: The present study assessed the efficacy of initial basal-supported oral therapy (BOT) with sitagliptin for achievement of glycemic control and subsequent switching from BOT to sitagliptin-based oral therapy. METHODS: Nineteen recently diagnosed type 2 diabetic patients who had received...

Descripción completa

Detalles Bibliográficos
Autor principal: Yoshioka, Keiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889313/
https://www.ncbi.nlm.nih.gov/pubmed/24127136
http://dx.doi.org/10.1007/s13300-013-0043-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889313/
https://www.ncbi.nlm.nih.gov/pubmed/24127136
http://dx.doi.org/10.1007/s13300-013-0043-x

Ejemplares similares